Correlated Drug Action as a Baseline Model for Combination Therapy in Patient Cohorts and Cell Cultures
Published in bioRxiv, 2023
1) CDA is a novel baseline model for studying drug combinations that considers potential correlations between drug efficacies.
2) The model can be applied in both temporal and dose domains to analyze different types of data, such as survival curves or dose-response curves.
3) The authors demonstrate the utility of tCDA at the clinical trial level and dCDA's applicability in experimental data assessment using a new metric, EOCDA.